Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients-Reference-Cited by-同舟云学术

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients

Published:2021-04-29 Issue:13 Volume:27 Page:3695-3703
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Zaccaria Gian Maria^ORCID,Bertamini Luca,Petrucci Maria Teresa,Offidani Massimo,Corradini Paolo,Capra Andrea,Romano Alessandra,Liberati Anna Marina^ORCID,Mannina Donato,de Fabritiis Paolo,Cascavilla Nicola^ORCID,Ruggeri Marina,Mina Roberto,Patriarca Francesca,Benevolo Giulia^ORCID,Belotti Angelo,Gaidano Gianluca^ORCID,Nagler Arnon,Hájek Roman^ORCID,Spencer Andrew,Sonneveld Pieter,Musto Pellegrino^ORCID,Boccadoro Mario,Gay Francesca^ORCID

Funder

No funding was provided for this contribution.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy;American Journal of Hematology;2024-04-13

2. A rational approach to functional high-risk myeloma;Hematology;2023-12-08

3. Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2023-11

4. Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling;Frontiers in Oncology;2023-10-02

5. An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT;Bone Marrow Transplantation;2023-05-09